Outcomes of Therapies and Resistance Mutations Following Non-Covalent Bruton's Tyrosine Kinase Inhibitor Treatment for Patients with Chronic Lymphocytic Leukemia and Richter Transformation
Blood (2022) 140 (Supplement 1): 9885–9888.
Currently there are no citedby results. Try again later.
